MONDAY, May 7 (HealthDay News) -- The diabetes drug rosiglitazone (brand name Avandia) dramatically increases the potency of platinum-based cancer drugs, U.S. researchers report.
In research with mice, scientists at the Dana-Farber Cancer Institute in Boston found that combining a platinum chemotherapy agent with rosiglitazone was as much as three times more effective at halting or shrinking tumors than using either of the drugs alone.
For more see:
http://news.yahoo.com/s/hsn/20070508...seffectiveness
Linear Mode
